terlipressin

Key facts

Mechanism of action

Vasopressin V2 receptor binding agent

Primary target: Vasopressin V1 receptor

Approval history

1. APHP200043 Phase 3 · PARItec · Hemoptysis, whatever the cause, with the exception of cystic
2. Terlipressin Unknown · Sun Yat-sen University · Septic Shock
3. Terlipressin Unknown · First People's Hospital · Terlipressin
4. Terlipressin treatment Unknown · Chinese Academy of · Septic Shock

1. terlipressin acetate Vasopressin V1 receptor binding agent

Frequently asked questions